ACY-738 |
Inhibitor of HDAC6
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| HDAC6 |
|
Inhibitor
10 nM - 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - HDAC1: 94 nM, HDAC2: 128 nM, HDAC3: 218 nM
Potency Assay Off-Target:
Enzyme assay, recombinant protein
In Cell Selectivity Assessment
Potency Assay Off-Target:
In RN46A-B12 cells, ACY-738 (2.5 uM) did not affect histone H3K9 acetylation.
Potency Cellular
In Vitro
HDAC6
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
male NIH Swiss mice
Dose: 5 mg/kg
Route of delivery:
Intraperitoneal
Plasma half life:
0.2 h
Organ of interest (O):
Brain
Target engagement assay:
In whole-brain lysate after treatment, alpha-tubulin acetylation increased in multiple brain regions (cortex, hippocampus, DRN, and cerebellum). An increase in alpha-tubulin acetlyation was not observed in the brains of flHDAC6^nestin-cre mice (neural-crest specific HDAC6 knock out in C57BL6 mice) beyond the already elevated levels. No changes in the acetylation of H3K9 were detected.
Reference: --
Negative Control Compounds
Chemical Information
| Molecular Formula | C14H14N4O2 |
| SMILEs | O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1 |
| InChI | InChI=1S/C14H14N4O2/c19-12(18-20)10-8-15-13(16-9-10)17-14(6-7-14)11-4-2-1-3-5-11/h1-5,8-9,20H,6-7H2,(H,18,19)(H,15,16,17) |
| Molecular weight | 270.11 Da |
| AlogP | 1.6967999999999999 |
| HBond acceptors | 6 |
| HBond donors | 3 |
| Atoms | 34 |
References
Publications
Cross References
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.